| A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells PNAS 118 (43), 1-12, 2021 | 71* | 2021 |
| Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer N Kotagiri, ML Cooper, M Rettig, C Egbulefu, J Prior, G Cui, P Karmakar, ... Nature communications 9 (1), 275, 2018 | 66 | 2018 |
| Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses P Karmakar, K Lee, S Sarkar, KA Wall, SJ Sucheck Bioconjugate chemistry 27 (1), 110-120, 2016 | 54 | 2016 |
| Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment X Su, Y Xu, GC Fox, J Xiang, KA Kwakwa, JL Davis, JI Belle, WC Lee, ... The Journal of clinical investigation 131 (20), 2021 | 47 | 2021 |
| Augmenting vaccine immunogenicity through the use of natural human anti-rhamnose antibodies MK Hossain, A Vartak, P Karmakar, SJ Sucheck, KA Wall ACS chemical biology 13 (8), 2130-2142, 2018 | 42 | 2018 |
| α‐Ketobenzothiazole serine protease inhibitors of aberrant HGF/c‐MET and MSP/RON kinase pathway signaling in cancer Z Han, PKW Harris, P Karmakar, T Kim, BY Owusu, SA Wildman, ... ChemMedChem 11 (6), 585-599, 2016 | 41 | 2016 |
| Drug Discovery and Development: New Advances V Gaitonde, P Karmakar, A Trivedi BoD–Books on Demand, 2020 | 34 | 2020 |
| Discovery of selective matriptase and hepsin serine protease inhibitors: useful chemical tools for cancer cell biology VC Damalanka, Z Han, P Karmakar, AJ O’Donoghue, F La Greca, T Kim, ... Journal of medicinal chemistry 62 (2), 480-490, 2018 | 28 | 2018 |
| Augmentation of dynamical persistence in networks through asymmetric interaction S Kundu, S Majhi, P Karmakar, D Ghosh, B Rakshit Europhysics Letters 123 (3), 30001, 2018 | 22 | 2018 |
| Synthesis of dispiropyrrolidines from chromone-3-carbaldehyde using sarcosine and ninhydrin as the source of an azomethine ylide SK Panja, P Karmakar, J Chakraborty, T Ghosh, C Bandyopadhyay Tetrahedron Letters 49 (28), 4397-4401, 2008 | 18 | 2008 |
| Mixed-Phase Synthesis of Glycopeptides Using a N-Peptidyl-2,4-dinitrobenzenesulfonamide–Thioacid Ligation Strategy P Karmakar, RS Talan, SJ Sucheck Organic letters 13 (19), 5298-5301, 2011 | 17 | 2011 |
| Promising recent strategies with potential clinical translational value to combat antibacterial resistant surge P Karmakar, V Gaitonde Medicines 6 (1), 21, 2019 | 12 | 2019 |
| Synthesis of α-L-rhamnosyl ceramide and evaluation of its binding with anti-rhamnose antibodies DE Long, P Karmakar, KA Wall, SJ Sucheck Bioorganic & medicinal chemistry 22 (19), 5279-5289, 2014 | 12 | 2014 |
| Introductory chapter: The modern-day drug discovery P Karmakar, A Trivedi, V Gaitonde Drug Discovery and Development-New Advances, 2020 | 4 | 2020 |
| Effect of linkers on the αvβ3 integrin targeting efficiency of cyclic RGD-conjugates. P Karmakar, D Grabowska, G Sudlow, K Ziabrev, N Sanyal, S Achilefu Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical …, 2018 | 4 | 2018 |
| Synthesis and reactivity of 3-(1-hydroxy-3-buten-1-yl) chromone P Karmakar, T Ghosh, D Chakrabarty, S Maiti, C Bandyopadhyay Journal of Chemical Research 2008 (4), 208-211, 2008 | 3 | 2008 |
| Analysis of Stable Chelate-free Gadolinium Loaded Titanium Dioxide Nanoparticles for MRI-Guided Radionuclide Stimulated Cancer Treatment L Fang, H Huang, JD Quirk, J Zheng, D Shen, B Manion, M Mixdorf, ... Current analytical chemistry 18 (7), 826, 2022 | 2 | 2022 |
| Induction of complementary immunogenic necroptosis and apoptosis cell death pathways inhibits cancer metastasis and relapse S Achilefu, C Egbulefu, K Black, X Su, P Karmakar, LM Habimana-Griffin, ... | | 2024 |
| Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting F Fontana, AK Esser, C Egbulefu, P Karmakar, X Su, JS Allen, Y Xu, ... Plos one 18 (12), e0293700, 2023 | | 2023 |
| Compounds for cancer therapy and imaging S Achilefu, D Grabowska, KS Gautam, P Karmakar US Patent App. 18/016,235, 2023 | | 2023 |
Samuel AchilefuUniversity of Texas Southwestern Medical Center, DallasGeverifieerd e-mailadres voor UTSouthwestern.edu
